Same-session salvage endoscopic submucosal dissection for an incompletely resected rectal neuroendocrine tumor

Endoscopy 2022; 54(10): E598-E599
DOI: 10.1055/a-1694-3367

E-Videos

Autor*innen

Vishal Garimella

Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
Vinay Chandrasekhara

Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA

References
1 Anthony LB, Strosberg JR, Klimstra DS. et al. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (NETs): well-differentiated NETs of the distal colon and rectum. Pancreas 2010; 39: 767-774
2 Choi HH, Kim JS, Cheung DY. et al. Which endoscopic treatment is the best for small rectal carcinoid tumors?. World J Gastrointest Endosc 2013; 5: 487-494
3 Kim J, Kim JH, Lee JY. et al. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor. BMC Gastroenterol 2018; 18: 77
4 Park HW, Byeon JS, Park YS. et al. Endoscopic submucosal dissection for treatment of rectal carcinoid tumors. Gastrointest Endosc 2010; 72: 143-149
5 Lee DS, Jeon SW, Park SY. et al. The feasibility of endoscopic submucosal dissection for rectal carcinoid tumors: comparison with endoscopic mucosal resection. Endoscopy 2010; 42: 647-651